Clinical Trial

Improving Lipid Optimization Quality and Treatment Options in ASCVD

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The goal of this project is to study different approaches to improve the utilization of guideline directed medicines to lower cholesterol in patients with or at high risk of atherosclerosis (cholesterol buildup in the arteries).
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-04-01 -> 2026-11-30 2026-05-19
minor Completion pushed: 2026-11-01 -> 2027-02-01 2026-05-19
Trial Details
NCT Number NCT06960655
Lead Sponsor Brigham and Women's Hospital
Collaborators: Merck Sharp & Dohme LLC
Conditions Hypercholesterolemia, ASCVD
Enrollment 300 participants
Start Date 2025-10-14
Primary Completion 2026-11-30 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-18